Inventor · disambiguated record
Pierre Martineau
Also filed as: MARTINEAU PIERRE · MARTINEAU PIERRE EMILE ULYSSE
9 granted patents·9 pending applications·2 citations·filing 2005–2023
75Inventor score
Files withINST NAT SANTE RECH MED7UNIV TOULOUSE 3 PAUL SABATIER3DARIAVACH PIONA2UNIV MONTPELLIER2INSERM (INSTITUT NAT DE LA SANTÉ ET DE LA RECHERCHÉ MÉDICALE)1
Top patents by PatentIndex Score
18 records- 0156US2025066471A1Anti-robo4 human monoclonal antibodies and uses thereof for the treatment of cancerINST NAT SANTE RECH MED·Filed 2023·Application pending·0 cites
- 0254US2024294658A1Hybrid molecule comprising a fibrin-derived citrullinated peptide and an antibody or antibody fragment which binds to cd38 and/or cd138, and uses thereofUNIV TOULOUSE 3 PAUL SABATIER·Filed 2022·Application pending·0 cites
- 0354US2025197476A1Hybrid molecule comprising an antibody fc fragment and at least one fibrin-derived citrullinated peptide, and uses thereofUNIV TOULOUSE 3 PAUL SABATIER·Filed 2022·Application pending·0 cites
- 0454US2024293455A1Armed nk cells for universal cell therapyUNIV MONTPELLIER·Filed 2021·Application pending·0 cites
- 0553US12441788B2Anti-müllerian inhibiting substance antibodies and uses thereofINST NAT SANTE RECH MED·Filed 2020·Granted Oct 14, 2025·0 cites·12 claims
- 0653US9504676B2Molecules inhibiting a metabolic pathway involving the Syk protein tyrosine kinase and method for identifying said moleculesDARIAVACH PIONA·Filed 2013·Granted Nov 29, 2016·1 cites·11 claims
- 0753US8841238B2Methods for producing active scFv antibodies and libraries thereforMARTINEAU PIERRE EMILE ULYSSE·Filed 2008·Granted Sep 23, 2014·1 cites·6 claims
- 0853US2024307538A1Immune cell which has an fc receptor on its surface and to which is grafted a hybrid molecule comprising an antibody fc fragment and at least one fibrin-derived citrulline peptide, and uses thereofUNIV TOULOUSE 3 PAUL SABATIER·Filed 2022·Application pending·0 cites
- 0947US12460009B2Monoclonal antibodies specific for IL20-Rb, encoding nucleic acids thereof and methods of use thereof to treat bacterial-induced exacerbation of chronic obstructive pulmonary diseaseINST NAT SANTE RECH MED·Filed 2020·Granted Nov 4, 2025·0 cites·19 claims
- 1042US2011112098A1Molecules inhibiting a metabolic pathway involving the syk protein tyrosine kinase and method for identifying said moleculesDARIAVACH PIONA·Filed 2009·Application pending·0 cites
- 1139US11186635B2Monoclonal antibodies binding to the CD160 transmembrane isoformINST NAT SANTE RECH MED·Filed 2017·Granted Nov 30, 2021·0 cites·14 claims
- 1237US2015346192A1Intracellular Phenotypic ScreeningSANOFI SA·Filed 2014·Application pending·0 cites
- 1335US10398774B2Human monoclonal antibodies against AXLINST NAT SANTE RECH MED·Filed 2015·Granted Sep 3, 2019·0 cites·14 claims
- 1435US2021188983A1Polypeptides for preparing drug conjugates capable of promoting apoptosis in a cell expressing an orexin receptorUNIV MONTPELLIER·Filed 2017·Application pending·0 cites
- 1533US10526415B2Human monoclonal antibodies fragments inhibiting both the Cath-D catalytic activity and its binding to the LRP1 receptorINST NAT SANTE RECH MED·Filed 2016·Granted Jan 7, 2020·0 cites·16 claims
- 1632US10758615B2Human monoclonal antibodies against orexin receptor type 1INST NAT SANTE RECH MED·Filed 2016·Granted Sep 1, 2020·0 cites·14 claims
- 1729US9110077B2Method for identifying a ligand capable of selectively modulating a functional cascade involving a target, and uses thereof for high-throughput screening of molecules of interestMARTINEAU PIERRE·Filed 2005·Granted Aug 18, 2015·0 cites·11 claims
- 1826US2018030135A1Human monoclonal antibodies against orexin receptor type 1INSERM (INSTITUT NAT DE LA SANTÉ ET DE LA RECHERCHÉ MÉDICALE)·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Pierre Martineau files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →